180 related articles for article (PubMed ID: 29777943)
1. Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer.
Dericioglu N; Gocmen R; Tan E
Clin Neurol Neurosurg; 2018 Jul; 170():117-119. PubMed ID: 29777943
[No Abstract] [Full Text] [Related]
2. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
3. Acquired Hemophilia and Anti-Hu Paraneoplastic Neurologic Syndrome in Small Cell Lung Cancer.
Aggelopoulou E; Evangelatos G; Tzavida K; Koulouri V; Lazaridis N
Am J Med Sci; 2017 Oct; 354(4):438-439. PubMed ID: 29078851
[No Abstract] [Full Text] [Related]
4. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.
Vernino S; Tuite P; Adler CH; Meschia JF; Boeve BF; Boasberg P; Parisi JE; Lennon VA
Ann Neurol; 2002 May; 51(5):625-30. PubMed ID: 12112110
[TBL] [Abstract][Full Text] [Related]
6. [Dysphagia and constipation as clinical manifestations of anti-Hu paraneoplastic syndrome].
Guardiola H; Vilaseca B; Martí S; de la Torre N
Med Clin (Barc); 2004 Sep; 123(10):398-9. PubMed ID: 15482710
[No Abstract] [Full Text] [Related]
7. Motor neuron disease as a treatment responsive paraneoplastic neurological syndrome in patient with small cell lung cancer, anti-Hu antibodies and limbic encephalitis.
Cheli M; Dinoto A; Ridolfi M; Sartori A; Stokelj D; Manganotti P
J Neurol Sci; 2019 May; 400():158-159. PubMed ID: 30953906
[No Abstract] [Full Text] [Related]
8. Small cell lung cancer and progressive retinopathy.
Morita M; Fukuhara T; Takahashi H; Maemondo M
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422332
[TBL] [Abstract][Full Text] [Related]
9. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
Sato C; Kano T; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
[TBL] [Abstract][Full Text] [Related]
10. Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features.
Waheed W; Boyd J; Khan F; Mount SL; Borden NM; Tandan R
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27571910
[TBL] [Abstract][Full Text] [Related]
11. Orthostatic hypotension secondary to CRMP-5 paraneoplastic autonomic neuropathy.
Neal AJ; Qian MY; Clinch AS; Le BH
J Clin Neurosci; 2014 May; 21(5):885-6. PubMed ID: 24268757
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic autoimmune encephalitis associated with CV2/CRMP-5 IgG antineuronal antibodies in a patient with thymoma.
Werry C; Götz F; Wurster U; Stangel M; Giess R; Heidenreich F; Windhagen A
J Neurol; 2009 Jan; 256(1):129-31. PubMed ID: 19267170
[No Abstract] [Full Text] [Related]
13. Paraneoplastic basal ganglia encephalitis associated with anti-CV2/CRMP-5 and anti-Yo antibodies in a patient with non-small-cell lung cancer.
Vakrakou A; Constantinides VC; Velonakis G; Tzartos JS; Stefanis L; Kapaki E; Paraskevas GP
Neurol Sci; 2020 Sep; 41(9):2649-2651. PubMed ID: 32307664
[No Abstract] [Full Text] [Related]
14. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
15. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
16. Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
Gozzard P; Chapman C; Vincent A; Lang B; Maddison P
PLoS One; 2015; 10(11):e0143558. PubMed ID: 26606748
[TBL] [Abstract][Full Text] [Related]
17. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic striatal encephalitis associated with anti-CV2].
Latorre-González G; López de Silanes-de Miguel C; Escribano-Gascón AB
Rev Neurol; 2008 Jun 1-15; 46(11):693-4. PubMed ID: 18509829
[No Abstract] [Full Text] [Related]
19. Subacute Supranuclear Palsy in anti-Hu Paraneoplastic Encephalitis.
Ohyagi M; Ishibashi S; Ohkubo T; Kobayashi Z; Mizusawa H; Yokota T; Emoto H; Kiyosawa M
Can J Neurol Sci; 2017 Jul; 44(4):444-446. PubMed ID: 28767032
[No Abstract] [Full Text] [Related]
20. Paraneoplastic sensorimotor neuropathy and ventral cauda equina nerve root enhancement as initial presentation of small cell lung carcinoma: a case study.
Alsaeed M; Lim CAR; Plecash A; Chen T
BMC Neurol; 2021 Sep; 21(1):374. PubMed ID: 34579672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
